
Sign up to save your podcasts
Or
Lilly releases higher dose Zepbound vials, reduces price for patients paying out of pocket. Meanwhile, the tirzepatide lawsuit heats up, with a potential ruing on preliminary injunction. The OFA strikes up a new battle with the FDA, suing them now over the end of the semaglutide shortage.
đź’Š Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
SOCIALS:
4.9
231231 ratings
Lilly releases higher dose Zepbound vials, reduces price for patients paying out of pocket. Meanwhile, the tirzepatide lawsuit heats up, with a potential ruing on preliminary injunction. The OFA strikes up a new battle with the FDA, suing them now over the end of the semaglutide shortage.
đź’Š Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
SOCIALS:
1,206 Listeners
334 Listeners
36 Listeners
59 Listeners
503 Listeners
272 Listeners
1,594 Listeners
380 Listeners
70 Listeners
56 Listeners
203 Listeners
181 Listeners
20 Listeners
100 Listeners
28 Listeners